article thumbnail

U.S. Pharmaceutical company improved quality of overall documentation saving time and filing delays

Impact Pharmaceutical Services

Challenge Syner-G was contracted by a US Pharmaceutical Company to help improve the quality of submission documentation generated during the manufacture of a Drug Substance intended for Phase II trials. The progress of the assignment was communicated to the client through weekly reports and regular virtual meetings.

article thumbnail

Leading direct-to-consumer marketing companies for pharmaceuticals

Pharmaceutical Technology

Pharmaceutical companies hold permission to market their products directly to consumers. The direct-to-consumer marketing companies for pharmaceuticals are increasingly moving online as it supports the digitisation of information, enabling patients to take control of their health.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Leading clinical dose companies in contract marketing

Pharmaceutical Technology

The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing or hiring decision. Prospects of clinical dose companies in contract marketing. Prospects of clinical dose companies in contract marketing.

article thumbnail

The Complete Guide to Pharmaceutical Detailing

Viseven

Pharmaceutical detailing is the most time-tested marketing format in the medical content world. Old-timer sales reps should remember how pharmaceutical companies reckoned face-to-face (F2F) visits with doctors as the most effective approach to achieving their sales targets. What is Pharmaceutical Detailing?

article thumbnail

Leading injectables (commercial dose) companies in contract marketing

Pharmaceutical Technology

The surge in diseases is spurring demand for constructive treatment solutions, which is expected to boost the sales of injectable pharmaceutical companies. Rapid absorption, faster drug action, lower risk of drug degradation by gastric secretion, and less concentration of the drug are driving the demand for injectable commercial doses.

article thumbnail

Practice makes perfect

pharmaphorum

If it’s a tight, complicated market, then doctors are going to be looking for the most compelling argument but lot of pharmaceutical companies fall down by not really presenting their product in the best possible light.”. If your team is fully aware of their value, they feel confident communicating with customers. “I

article thumbnail

Reshaping events in pharma

pharmaphorum

Linking events with the company’s broader content strategy will help regularly communicate more in-depth insights, and delivering content in new and engaging ways, such as gamification or extended reality, will draw in your audience. Dave Yates is a global product director at GSK Pharmaceuticals. About the interviewees.